STRATA Skin Sciences(SSKN)
icon
搜索文档
STRATA Skin Sciences(SSKN) - 2023 Q4 - Annual Results
2024-03-28 04:44
收入情况 - 2023年第四季度收入为870万美元,全年收入为3340万美元[2] - 全球循环收入为560万美元,国内循环账单为530万美元[2] - 2023年全年收入为3340万美元,全球循环收入为2150万美元[9] 毛利情况 - 第四季度毛利为480万美元,占收入的55%[5] - 全年毛利为1850万美元,占收入的55.3%[10] - 2023年STRATA Skin Sciences公司的毛利润为18461千美元,较2022年21768千美元有所下降[26] 成本情况 - 第四季度销售和营销成本为280万美元,总务和行政成本为280万美元[6] 净利情况 - 第四季度净亏损为380万美元,每股基本和摊薄普通股亏损为0.11美元[7] - 全年净亏损为1080万美元,每股基本和摊薄普通股亏损为0.31美元[13] - 2023年STRATA Skin Sciences公司的净亏损为10830千美元,较2022年5549千美元有所增加[26] 现金情况 - 2023年12月31日的现金、现金等价物和受限现金为810万美元[13]
STRATA Skin Sciences(SSKN) - 2023 Q3 - Earnings Call Transcript
2023-11-15 10:24
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q3 2023 Earnings Conference Call November 14, 2023 4:30 PM ET Company Participants Rich Cockrell – Investor Relations Dolev Rafaeli – President and Chief Executive Officer Chris Lesovitz – Chief Financial Officer Conference Call Participants Jeffrey Cohen – Ladenburg Thalmann Operator Greetings, and welcome to the STRATA Skin Sciences Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session ...
STRATA Skin Sciences(SSKN) - 2023 Q3 - Quarterly Report
2023-11-15 06:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to ___________ Commission File Number 0-51481 STRATA SKIN SCIENCES, INC. (Exact name of registrant as specified in its charter) Delaware 13-3986004 (State ...
STRATA Skin Sciences(SSKN) - 2023 Q2 - Earnings Call Transcript
2023-08-10 09:24
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Nicole Jones - IR Bob Moccia - CEO Chris Lesovitz - CFO Conference Call Participants Destiny Hance - Ladenburg Thalmann Operator Greetings. Welcome to STRATA Skin Sciences' 2Q 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is bein ...
STRATA Skin Sciences(SSKN) - 2023 Q2 - Quarterly Report
2023-08-10 04:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to ___________ Commission File Number 0-51481 STRATA SKIN SCIENCES, INC. (Exact name of registrant as specified in its charter) Delaware 13-3986004 (State or o ...
STRATA Skin Sciences(SSKN) - 2023 Q1 - Earnings Call Transcript
2023-05-16 08:45
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q1 2023 Results Conference Call May 15, 2023 4:30 PM ET Company Participants Bob Moccia - Chief Executive Officer Chris Lesovitz - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Operator Greetings. Welcome to the STRATA Skin Sciences First Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen only mode. A question-and-answer session will follow the formal presentation [Operator Instructions]. Pl ...
STRATA Skin Sciences(SSKN) - 2023 Q1 - Quarterly Report
2023-05-16 04:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to ___________ Commission File Number 0-51481 STRATA SKIN SCIENCES, INC. (Exact name of registrant as specified in its charter) Delaware 13-3986004 (State or ...
STRATA Skin Sciences(SSKN) - 2022 Q4 - Earnings Call Transcript
2023-04-01 12:30
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q4 2022 Earnings Conference Call March 31, 2023 8:30 AM ET Company Participants Bob Moccia - CEO Chris Lesovitz - CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Operator Hello, and welcome to the STRATA Skin Sciences Fourth Quarter 2022 and Full Year Earnings Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to [indiscernible]. Please go ahead. Unidentified Compa ...
STRATA Skin Sciences(SSKN) - 2022 Q4 - Annual Report
2023-04-01 05:13
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 0-11635 STRATA SKIN SCIENCES, INC. (Exact name of registrant as specified in its charter) Delaware 13-3986004 (State or Other Jurisdiction of (I.R.S. Employer incorporation or Organ ...
STRATA Skin Sciences(SSKN) - 2022 Q1 - Earnings Call Presentation
2022-05-13 22:58
| --- | --- | --- | --- | --- | |-------|-------|-------|-------|---------------------------------------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Driving Value to Dermatology Partners | | | | | | Matching Patients with Clinics | | | | | | | | | | | | Investor Presentation April 2022 • | December 2020 Safe Harbor Statement 2 This presentation includes "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These st ...